Review
Version 1
Preserved in Portico This version is not peer-reviewed
Keap 1: The New Janus Word on the Block
*
and
*
Version 1
: Received: 9 April 2022 / Approved: 11 April 2022 / Online: 11 April 2022 (10:39:31 CEST)
How to cite: Marcus, L.; Aye, Y. Keap 1: The New Janus Word on the Block. Preprints 2022, 2022040093. https://doi.org/10.20944/preprints202204.0093.v1 Marcus, L.; Aye, Y. Keap 1: The New Janus Word on the Block. Preprints 2022, 2022040093. https://doi.org/10.20944/preprints202204.0093.v1
Abstract
Here we draw insights from the latest serendipitous findings made on the opposing roles of a validated drug-target protein Keap1. We weigh up how natural reactive electrophiles and electrophilic small-molecule drugs in clinical use directly impinge on seemingly conflicting, yet both Keap1-electrophile-modification-dependent, cell-survival- vs. cell-death-promoting behaviors. In the process, we convey how understanding reactive chemical-signal regulation at a single-protein-specific level is an enabling necessity in deconstructing otherwise intricate reactive-small-molecule-responsive cellular pathways. We hope this opinion piece further spurs the broader interests of basic and pharmaceutical research communities toward better understanding of molecular mechanisms underpinning reactive small-molecule-regulated signaling subsystems.
Keywords
Electrophile signaling; drug mechanism; immunology; antioxidant response; apoptosis
Subject
Biology and Life Sciences, Immunology and Microbiology
Copyright: This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Comments (0)
We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.
Leave a public commentSend a private comment to the author(s)
* All users must log in before leaving a comment
